Health : Page 46

MedAlliance SELUTION SLR, first drug-eluting balloon to receive coronary de novo IDE approval

January 11, 2023 SELUTION SLR, MedAlliance\'s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.

Uganda declares end of Ebola outbreak

January 11, 2023 Uganda declared an end to an Ebola virus outbreak.

Nine-year-old girl infected with A-H5 strain of avian flu, first in Ecuador

January 11, 2023 A nine-year-old girl in central Ecuador has been infected with the A-H5 strain of avian influenza, becoming the first human infected with the avian flu strain in the country, the Ecuadorian Ministry of Public Health confirmed on Tuesday.

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine doses

January 10, 2023 In a recent correspondence published in The Lancet Infectious Diseases journal, researchers in Germany assessed the neutralization sensitivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB.1 lineage.

Argentina issues guidelines for prevention of trichinosis and care of people's health

January 10, 2023 Trichinellosis is considered a notifiable disease established by official regulations.

Bangladesh declared free from DDT pesticide

January 9, 2023 Bangladesh has been declared free from dangerous Dichlorodiphenyltrichloroethane pesticide, commonly known as DDT pesticide.

ECDC: No fear of COVID Kraken mutation

January 9, 2023 XBB.1.5 or Kraken is a sub-lineage of SARS-CoV-2 XBB, with an additional spike RBD mutation S486P, European Centre for Disease Prevention and Control (ECDC) said.

FDA approves new Alzheimer's drug that appears to slow illness

January 8, 2023 The U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease.

FDA grants priority review of glofitamab for lymphoma

January 8, 2023 Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) and granted priority review for glofitamab, an investigational CD20xCD3 T-cell engaging bispecific antibody, for the treatment of adult patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) after two or more lines of systemic therapy.

Severe bacterial infections on rise in New South Wales, concerning health authority

January 6, 2023 Health authority in the Australian state of New South Wales (NSW) on Friday urged local communities to stay alert to signs and symptoms of invasive bacterial infections, as related cases recently increased across the state.

MedinCell announces positive results for the SAIVE study in prevention of contact COVID-19 infection

January 6, 2023 The study conducted in 399 participants met its primary efficacy endpoint with a reduction of 72% of COVID-19 infection in the group treated with daily oral administration of ivermectin compared to the placebo group.

FAA: Pilots and air traffic controllers may receive Johnson & Johnson's vaccine, with appropriate precautions

January 6, 2023 Following the Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for Johnson & Johnson’s Janssen COVID-19 vaccine, the Federal Aviation Administration (FAA) has determined that pilots and others who perform safety sensitive duties may receive the vaccine under the conditions of their FAA-issued airman medical certification.